Fig. 3.
Selectivity of the Egr inhibitor construct.Top, PC12 cells were transfected with a luciferase reporter plasmid driven by a segment of the Egr1 promoter that contains four SRE sites. Bottom, NGF treatment increases luciferase activity in extracts prepared from these cells. This increase is not blocked by cotransfection with the Egr inhibitor construct.
